Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone

Clinical Pharmacology & Therapeutics

Volumn 56, Issue 1, 1994, Pages 86-99

  Rose, Jed E ^a   Behm, Frederique M ^a   Westman, Eric C ^a   Levin, Edward D ^a   Stein, Roy M ^a   Ripka, Gail V ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MECAMYLAMINE; NICOTINE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ADULT; AFFECT; BLOOD PRESSURE; BREATH TESTS; CARBON MONOXIDE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HEART RATE; HUMANS; MALE; MECAMYLAMINE; NICOTINE; PATIENT COMPLIANCE; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME;

EID: 0027931492     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.1994.105     Document Type: Article

References (0)